Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales Market Report 2017

世界の慢性閉塞性肺疾患(COPD)薬市場:販売動向2017

◆タイトル:Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales Market Report 2017
◆商品コード:QYR70328247
◆調査・発行会社:QYResearch
◆発行日:2017年2月15日
◆ページ数:106
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥428,000見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD8,000 ⇒換算¥856,000見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、慢性閉塞性肺疾患(COPD)薬の世界市場について調査・分析し、慢性閉塞性肺疾患(COPD)薬のメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、地域別販売分析(アメリカ、中国、ヨーロッパ、日本、東南アジア、インド)、価格動向、企業動向、慢性閉塞性肺疾患(COPD)薬産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・慢性閉塞性肺疾患(COPD)薬市場概要
・慢性閉塞性肺疾患(COPD)薬のメーカー別販売量・メーカー別シェア
・慢性閉塞性肺疾患(COPD)薬の世界市場:種類別販売量・市場シェア
・慢性閉塞性肺疾患(COPD)薬の世界市場:用途別販売量・市場シェア
・慢性閉塞性肺疾患(COPD)薬の世界市場:地域別販売量・市場シェア
・慢性閉塞性肺疾患(COPD)薬のアメリカ市場規模
・慢性閉塞性肺疾患(COPD)薬の中国市場規模
・慢性閉塞性肺疾患(COPD)薬のヨーロッパ市場規模
・慢性閉塞性肺疾患(COPD)薬の日本市場規模
・慢性閉塞性肺疾患(COPD)薬の東南アジア市場規模
・慢性閉塞性肺疾患(COPD)薬のインド市場規模
・慢性閉塞性肺疾患(COPD)薬のメーカー別分析(企業概要、事業概要、商品概要、収益、価格等)
・慢性閉塞性肺疾患(COPD)薬のコスト分析・価格動向
・慢性閉塞性肺疾患(COPD)薬の産業チェーン(サプライチェーン分析)
・慢性閉塞性肺疾患(COPD)薬のマーケティング戦略・販売チャネル、流通業者
・慢性閉塞性肺疾患(COPD)薬市場への影響要因分析
・慢性閉塞性肺疾患(COPD)薬の世界市場予測
・慢性閉塞性肺疾患(COPD)薬のアメリカ市場予測
・慢性閉塞性肺疾患(COPD)薬の中国市場予測
・慢性閉塞性肺疾患(COPD)薬のヨーロッパ市場予測
・慢性閉塞性肺疾患(COPD)薬の日本市場予測
・慢性閉塞性肺疾患(COPD)薬の東南アジア市場予測
・慢性閉塞性肺疾患(COPD)薬のインド市場予測
・慢性閉塞性肺疾患(COPD)薬の種類別世界市場予測
・慢性閉塞性肺疾患(COPD)薬の用途別世界市場予測
...

Notes:Sales, means the sales volume of Chronic Obstructive Pulmonary Disease (COPD) Drugs
Revenue, means the sales value of Chronic Obstructive Pulmonary Disease (COPD) Drugs

This report studies sales (consumption) of Chronic Obstructive Pulmonary Disease (COPD) Drugs in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
GSK
Novartis
Boehringer Ingelheim
Sunovion Pharmaceuticals
Perforomist
SPIRIVA
Almirall
Striverdi

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Chronic Obstructive Pulmonary Disease (COPD) Drugs in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Chronic Obstructive Pulmonary Disease (COPD) Drugs in each application, can be divided into
Application 1
Application 2

【レポートの目次】

Table of Contents

Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales Market Report 2017
1 Chronic Obstructive Pulmonary Disease (COPD) Drugs Overview
1.1 Product Overview and Scope of Chronic Obstructive Pulmonary Disease (COPD) Drugs
1.2 Classification of Chronic Obstructive Pulmonary Disease (COPD) Drugs
1.2.1 Type I
1.2.2 Type II
1.3 Application of Chronic Obstructive Pulmonary Disease (COPD) Drugs
1.3.1 Application 1
1.3.2 Application 2
1.4 Chronic Obstructive Pulmonary Disease (COPD) Drugs Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Chronic Obstructive Pulmonary Disease (COPD) Drugs (2012-2022)
1.5.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Growth Rate (2012-2022)
1.5.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2012-2022)

2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Competition by Manufacturers, Type and Application
2.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Competition by Manufacturers
2.1.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Share by Manufacturers (2012-2017)
2.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs (Volume and Value) by Type
2.2.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Market Share by Type (2012-2017)
2.2.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Market Share by Type (2012-2017)
2.3 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs (Volume and Value) by Regions
2.3.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Market Share by Regions (2012-2017)
2.3.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Market Share by Regions (2012-2017)
2.4 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs (Volume) by Application

3 United States Chronic Obstructive Pulmonary Disease (COPD) Drugs (Volume, Value and Sales Price)
3.1 United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Value (2012-2017)
3.1.1 United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Growth Rate (2012-2017)
3.1.2 United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2012-2017)
3.1.3 United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales Price Trend (2012-2017)
3.2 United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Market Share by Manufacturers
3.3 United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Market Share by Type
3.4 United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Market Share by Application

4 China Chronic Obstructive Pulmonary Disease (COPD) Drugs (Volume, Value and Sales Price)
4.1 China Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Value (2012-2017)
4.1.1 China Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Growth Rate (2012-2017)
4.1.2 China Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2012-2017)
4.1.3 China Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales Price Trend (2012-2017)
4.2 China Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Market Share by Manufacturers
4.3 China Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Market Share by Type
4.4 China Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Market Share by Application

5 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs (Volume, Value and Sales Price)
5.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Value (2012-2017)
5.1.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Growth Rate (2012-2017)
5.1.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2012-2017)
5.1.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales Price Trend (2012-2017)
5.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Market Share by Manufacturers
5.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Market Share by Type
5.4 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Market Share by Application

6 Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs (Volume, Value and Sales Price)
6.1 Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Value (2012-2017)
6.1.1 Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Growth Rate (2012-2017)
6.1.2 Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2012-2017)
6.1.3 Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales Price Trend (2012-2017)
6.2 Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Market Share by Manufacturers
6.3 Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Market Share by Type
6.4 Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Market Share by Application
7 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs (Volume, Value and Sales Price)
7.1 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Value (2012-2017)
7.1.1 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales Price Trend (2012-2017)
7.2 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Market Share by Manufacturers
7.3 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Market Share by Type
7.4 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Market Share by Application
8 India Chronic Obstructive Pulmonary Disease (COPD) Drugs (Volume, Value and Sales Price)
8.1 India Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Value (2012-2017)
8.1.1 India Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Growth Rate (2012-2017)
8.1.2 India Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2012-2017)
8.1.3 India Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales Price Trend (2012-2017)
8.2 India Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Market Share by Manufacturers
8.3 India Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Market Share by Type
8.4 India Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Market Share by Application

9 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Manufacturers Analysis
9.1 GSK
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Type, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 GSK Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Novartis
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Type, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Novartis Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Boehringer Ingelheim
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Type, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Sunovion Pharmaceuticals
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Type, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Sunovion Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Perforomist
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Type, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Perforomist Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 SPIRIVA
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Type, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 SPIRIVA Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Almirall
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Type, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Almirall Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Striverdi
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Type, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Striverdi Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview

10 Chronic Obstructive Pulmonary Disease (COPD) Drugs Maufacturing Cost Analysis
10.1 Chronic Obstructive Pulmonary Disease (COPD) Drugs Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Chronic Obstructive Pulmonary Disease (COPD) Drugs
10.3 Manufacturing Process Analysis of Chronic Obstructive Pulmonary Disease (COPD) Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Chronic Obstructive Pulmonary Disease (COPD) Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Chronic Obstructive Pulmonary Disease (COPD) Drugs Major Manufacturers in 2015
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Forecast (2017-2022)
14.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Price and Trend Forecast (2017-2022)
14.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Picture of Chronic Obstructive Pulmonary Disease (COPD) Drugs
Table Classification of Chronic Obstructive Pulmonary Disease (COPD) Drugs
Figure Global Sales Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Chronic Obstructive Pulmonary Disease (COPD) Drugs
Figure Global Sales Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2012-2022)
Figure China Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2012-2022)
Figure Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2012-2022)
Figure Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2012-2022)
Figure India Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2012-2022)
Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Growth Rate (2012-2022)
Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2012-2022)
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales of Key Manufacturers (2012-2017)
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales Share by Manufacturers (2012-2017)
Figure 2015 Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales Share by Manufacturers
Figure 2016 Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales Share by Manufacturers
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue by Manufacturers (2012-2017)
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue Share by Manufacturers
Table 2016 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue Share by Manufacturers
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Market Share by Type (2012-2017)
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs by Type (2012-2017)
Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales Growth Rate by Type (2012-2017)
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Market Share by Type (2012-2017)
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs by Type (2012-2017)
Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Market Share by Regions (2012-2017)
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales Share by Regions (2012-2017)
Figure Sales Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs by Regions (2012-2017)
Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales Growth Rate by Regions (2012-2017)
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Market Share by Regions (2012-2017)
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs by Regions (2012-2017)
Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue Growth Rate by Regions (2012-2017)
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Market Share by Application (2012-2017)
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Chronic Obstructive Pulmonary Disease (COPD) Drugs by Application (2012-2017)
Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Growth Rate (2012-2017)
Figure United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2012-2017)
Figure United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales Price Trend (2012-2017)
Table United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales by Manufacturers (2012-2017)
Table United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Share by Manufacturers (2012-2017)
Table United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales by Type (2012-2017)
Table United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Share by Type (2012-2017)
Table United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales by Application (2012-2017)
Table United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Share by Application (2012-2017)
Figure China Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Growth Rate (2012-2017)
Figure China Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2012-2017)
Figure China Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales Price Trend (2012-2017)
Table China Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales by Manufacturers (2012-2017)
Table China Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Share by Manufacturers (2012-2017)
Table China Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales by Type (2012-2017)
Table China Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Share by Type (2012-2017)
Table China Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales by Application (2012-2017)
Table China Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Share by Application (2012-2017)
Figure Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Growth Rate (2012-2017)
Figure Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2012-2017)
Figure Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales Price Trend (2012-2017)
Table Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales by Manufacturers (2012-2017)
Table Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Share by Manufacturers (2012-2017)
Table Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales by Type (2012-2017)
Table Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Share by Type (2012-2017)
Table Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales by Application (2012-2017)
Table Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Share by Application (2012-2017)
Figure Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Growth Rate (2012-2017)
Figure Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2012-2017)
Figure Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales Price Trend (2012-2017)
Table Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales by Manufacturers (2012-2017)
Table Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Share by Manufacturers (2012-2017)
Table Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales by Type (2012-2017)
Table Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Share by Type (2012-2017)
Table Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales by Application (2012-2017)
Table Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Share by Application (2012-2017)
Figure Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Growth Rate (2012-2017)
Figure Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales Price Trend (2012-2017)
Table Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales by Manufacturers (2012-2017)
Table Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Share by Manufacturers (2012-2017)
Table Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales by Type (2012-2017)
Table Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Share by Type (2012-2017)
Table Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales by Application (2012-2017)
Table Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Share by Application (2012-2017)
Figure India Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Growth Rate (2012-2017)
Figure India Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2012-2017)
Figure India Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales Price Trend (2012-2017)
Table India Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales by Manufacturers (2012-2017)
Table India Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Share by Manufacturers (2012-2017)
Table India Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales by Type (2012-2017)
Table India Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Share by Type (2012-2017)
Table India Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales by Application (2012-2017)
Table India Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Share by Application (2012-2017)
Table GSK Basic Information List
Table GSK Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GSK Chronic Obstructive Pulmonary Disease (COPD) Drugs Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Chronic Obstructive Pulmonary Disease (COPD) Drugs Global Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Chronic Obstructive Pulmonary Disease (COPD) Drugs Global Market Share (2012-2017)
Table Sunovion Pharmaceuticals Basic Information List
Table Sunovion Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sunovion Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Drugs Global Market Share (2012-2017)
Table Perforomist Basic Information List
Table Perforomist Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Perforomist Chronic Obstructive Pulmonary Disease (COPD) Drugs Global Market Share (2012-2017)
Table SPIRIVA Basic Information List
Table SPIRIVA Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure SPIRIVA Chronic Obstructive Pulmonary Disease (COPD) Drugs Global Market Share (2012-2017)
Table Almirall Basic Information List
Table Almirall Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Almirall Chronic Obstructive Pulmonary Disease (COPD) Drugs Global Market Share (2012-2017)
Table Striverdi Basic Information List
Table Striverdi Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Striverdi Chronic Obstructive Pulmonary Disease (COPD) Drugs Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Chronic Obstructive Pulmonary Disease (COPD) Drugs
Figure Manufacturing Process Analysis of Chronic Obstructive Pulmonary Disease (COPD) Drugs
Figure Chronic Obstructive Pulmonary Disease (COPD) Drugs Industrial Chain Analysis
Table Raw Materials Sources of Chronic Obstructive Pulmonary Disease (COPD) Drugs Major Manufacturers in 2015
Table Major Buyers of Chronic Obstructive Pulmonary Disease (COPD) Drugs
Table Distributors/Traders List
Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate Forecast (2017-2022)
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales Forecast by Regions (2017-2022)
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales Forecast by Type (2017-2022)
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales Forecast by Application (2017-2022)



【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[世界の慢性閉塞性肺疾患(COPD)薬市場:販売動向2017] (Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Sales Market Report 2017 / QYR70328247)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆